C Champions Oncology Inc
C
Отворен
СекторЗдравеопазване
6.17 -0.96
Преглед
Промяна на цената на акция
24 ч
Минимум
5.8100000000000005
Максимум
6.31
Приходи | -514K -278K |
|---|---|
Продажби | 1.5M 17M |
P/E Средно за сектора | 35.118 49.712 |
EPS | -0.02 |
Марж на печалбата | -1.679 |
Служители | 213 |
EBITDA | -508K 104K |
Следващи печалби | 22.07.2026 г. |
|---|
Пазарна капитализация | 5.1M 88M |
|---|---|
Предишно отваряне | 7.13 |
Предишно затваряне | 6.17 |
Настроения в новините
By Acuity
100%
0%
315 / 342 Класиране в Healthcare
Champions Oncology Inc Графика
Миналото представяне не гарантира бъдещи резултати.
Относно Champions Oncology Inc
Champions Oncology, Inc., a technology-enabled research company, provides transformative technology solutions for drug discovery and development in the United States. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. In addition, it offers Lumin Bioinformatics, an oncology data-driven software program which contains comprehensive information derived from research services and clinical studies. The company markets its products through internet, word of mouth, and sales force to pharmaceutical and biotechnology companies. Champions Oncology, Inc. was formerly known as Champions Biotechnology, Inc. and changed its name to Champions Oncology, Inc. in April 2011. The company was incorporated in 1985 and is headquartered in Hackensack, New Jersey.